{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:05:28Z","timestamp":1773662728037,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05218-w","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:04:58Z","timestamp":1768989898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemical constituents of Rhazya stricta as potential Aurora kinase A inhibitors for targeting HER2-negative breast cancer: an integrated in-silico and in-vitro study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ikhlas","family":"Yusaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"1","key":"5218_CR1","volume":"4","author":"MR Sarwar","year":"2017","unstructured":"Sarwar MR, Saqib A. Cancer prevalence, incidence, and mortality rates in Pakistan in 2012. Clin Med. 2017;4(1):1288773.","journal-title":"Clin Med"},{"key":"5218_CR2","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO. Ram\u00edrez-Valdespino, C. A. Subtypes of breast cancer. Biol Cancer 2022. 31\u201342","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"issue":"6","key":"5218_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv048","volume":"107","author":"BA Kohler","year":"2015","unstructured":"Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the Nation on the status of cancer, 1975\u20132011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.","journal-title":"J Natl Cancer Inst"},{"key":"5218_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13008-018-0040-6","volume":"13","author":"E Willems","year":"2018","unstructured":"Willems E, Dedobbeleer M, Digregorio M, Lombard A, Lumapat PN, Rogister B. The functional diversity of Aurora kinases: a comprehensive review. Cell Div. 2018;13:7. https:\/\/doi.org\/10.1186\/s13008-018-0040-6.","journal-title":"Cell Div"},{"issue":"5","key":"5218_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2014.14","volume":"34","author":"B Goldenson","year":"2015","unstructured":"Goldenson B, Crispino JD. The Aurora kinases in cell cycle and leukemia. Oncogene. 2015;34(5):537\u201345. https:\/\/doi.org\/10.1038\/onc.2014.14.","journal-title":"Oncogene"},{"key":"5218_CR6","doi-asserted-by":"publisher","unstructured":"Shrihastini V, Muthuramalingam P, Adarshan S, Sujitha M, Chen JT, Shin H, Ramesh M. Plant Derived Bioactive Compounds, Their Anti-Cancer Effects, and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview. Cancers (Basel) 2021;13(24):6222.https:\/\/doi.org\/10.3390\/cancers13246222.","DOI":"10.3390\/cancers13246222"},{"issue":"16","key":"5218_CR7","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer. 2017;8(16):3131\u201341. https:\/\/doi.org\/10.7150\/jca.18457.","journal-title":"J Cancer"},{"issue":"4","key":"5218_CR8","first-page":"701","volume":"12","author":"M Lacroix","year":"2004","unstructured":"Lacroix M, Haibe-Kains B, Hennuy B, Laes J-F, Lallemand F, Gonze I, Sotiriou C. Gene regulation by phorbol 12-Myristate 13-Acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes. Oncol Res. 2004;12(4):701\u20137.","journal-title":"Oncol Res"},{"issue":"1","key":"5218_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2011.06.020","volume":"48","author":"R Wolters","year":"2012","unstructured":"Wolters R, Regierer A, Schwentner L, Geyer V, Possinger K, Kreienberg R, W\u00f6ckel A. A comparison of international breast cancer guidelines: do the National guidelines differ in treatment recommendations? Eur J Cancer. 2012;48(1):1\u201311.","journal-title":"Eur J Cancer"},{"issue":"8","key":"5218_CR10","first-page":"1572","volume":"37","author":"VM Bola\u00f1os-Garc\u00eda","year":"2005","unstructured":"Bola\u00f1os-Garc\u00eda VM, Cundell C. Aurora kinases. Trends J Biol. 2005;37(8):1572\u20137.","journal-title":"Trends J Biol"},{"key":"5218_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sjbs.2015.10.017","volume":"24","author":"N Bukhari","year":"2015","unstructured":"Bukhari N, Al-Otaibi R, Ibrahim M. Phytochemical and taxonomic evaluation of Rhazya stricta in Saudi Arabia. Saudi J Biol Sci. 2015;24:1\u20136. https:\/\/doi.org\/10.1016\/j.sjbs.2015.10.017.","journal-title":"Saudi J Biol Sci"},{"key":"5218_CR12","first-page":"205","volume":"6","author":"K Shaltout","year":"2002","unstructured":"Shaltout K, El-Sheikh M. Vegetation of the urban habitats in the Nile Delta Region, Egypt. Urb Ecol. 2002;6:205\u201321.","journal-title":"Urb Ecol"},{"key":"5218_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2020.00733","volume":"11","author":"W Cui","year":"2020","unstructured":"Cui W, Aouidate A, Wang S, Yu Q, Li Y, Yuan S. Discovering anti-cancer drugs via computational methods. Front Pharmacol. 2020;11:733.","journal-title":"Front Pharmacol"},{"issue":"9","key":"5218_CR14","first-page":"7513","volume":"45","author":"LV Bel\u2019skaya","year":"2023","unstructured":"Bel\u2019skaya LV, Gundyrev IA, Solomatin DV. The role of amino acids in the diagnosis, risk assessment, and treatment of breast cancer: a review. J Cancer Res Clin Oncol. 2023;45(9):7513\u201337.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5218_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.991369","volume":"10","author":"U Dasmahapatra","year":"2022","unstructured":"Dasmahapatra U, Kumar CK, Das S, Subramanian PT, Murali P, Isaac AE, et al. In-Silico molecular modelling, MM\/GBSA binding free energy, and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents. Front Chem. 2022;10:991369. https:\/\/doi.org\/10.3389\/fchem.2022.991369.","journal-title":"Front. Chem."},{"issue":"1","key":"5218_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1158\/1541-7786.MCR-16-0211","volume":"15","author":"M Miyawaki","year":"2017","unstructured":"Miyawaki M, Yasuda H, Tani T, Hamamoto J, Arai D, Ishioka K, et al. Overcoming EGFR bypass signal-induced acquired resistance to ALK tyrosine kinase inhibitors in ALK-translocated lung cancer. Mol Cancer Res. 2017;15(1):106\u201314.","journal-title":"Mol. Cancer Res."},{"key":"5218_CR17","doi-asserted-by":"crossref","unstructured":"Yang N, Ray S, Krafts K. Cell Proliferation. In: Encyclopedia of Toxicology: Third Edition. Elsevier; 2014. p. 761\u20135.","DOI":"10.1016\/B978-0-12-386454-3.00274-8"},{"key":"5218_CR18","unstructured":"Riss TL, Moravec RA, Niles AL, Duellman S, Benink HA, Worzella TJ, Minor LJ. Cell viability assays. Assay Guidance Man 2016."},{"key":"5218_CR19","doi-asserted-by":"crossref","unstructured":"McGaw LJ, Elgorashi EE, Eloff JN. Cytotoxicity of African Medicinal Plants against Normal Animal and Human Cells. In: Toxicological Survey of African Medicinal Plants. Elsevier; 2014. p. 181\u2013233.","DOI":"10.1016\/B978-0-12-800018-2.00008-X"},{"key":"5218_CR20","unstructured":"Farghadani R, Haerian BS, Ebrahim NA, Muniandy S. 35 year research history of cytotoxicity and cancer: a quantitative and qualitative analysis. Asian Pac J Cancer Prev. 2016;17(7):3139\u201345."},{"key":"5218_CR21","doi-asserted-by":"crossref","unstructured":"Saito S, Wuputra K, Kato K, Yokoyama K. The Progress in the Study of Reprogramming to Acquire the Features of Stem Cells in iPSCs and Cancers. In: Recent Advances in iPSC Technology. Elsevier; 2021. p. 87\u2013114.","DOI":"10.1016\/B978-0-12-822231-7.00002-3"},{"key":"5218_CR22","doi-asserted-by":"crossref","unstructured":"Hunter T, Cooper JA. Protein-Tyrosine kinases. Annu Rev Biochem. 1985;54(1):897\u2013930.","DOI":"10.1146\/annurev.bi.54.070185.004341"},{"key":"5218_CR23","doi-asserted-by":"crossref","unstructured":"Cicenas J, Zalyte E, Bairoch A, Gaudet P. Kinases and cancer. Cancer signaling and therapeutics. Volume 10. MDPI; 2018: 63.","DOI":"10.3390\/cancers10030063"},{"key":"5218_CR24","doi-asserted-by":"crossref","unstructured":"Cicenas J, Kalyan K, Sorokinas A, Jatulyte A, Valiunas D, Kaupinis A, et al. Highlights of the latest advances in research on CDK inhibitors. J Chem Biol. 2014;6(4):2224\u201342.","DOI":"10.3390\/cancers6042224"},{"key":"5218_CR25","doi-asserted-by":"crossref","unstructured":"Cicenas J, Kalyan K, Sorokinas A, Stankunas E, Levy J, Meskinyte I, Valius M. Roscovitine in cancer and other diseases. Acta Med Lit. 2015;3(10).2224\u201342.","DOI":"10.3390\/cancers6042224"},{"key":"5218_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00432-011-1039-4","volume":"137","author":"J Cicenas","year":"2011","unstructured":"Cicenas J, Valius M. The CDK inhibitors in cancer research and therapy. J Cancer Res Clin Oncol. 2011;137:1409\u201318.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5218_CR27","first-page":"1","volume":"33","author":"J Cicenas","year":"2016","unstructured":"Cicenas J, Cicenas E. Multi-kinase inhibitors, AURKs, and cancer. Mol Oncol. 2016;33:1\u201311.","journal-title":"Mol Oncol"},{"issue":"5","key":"5218_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13050947","volume":"13","author":"J Cicenas","year":"2021","unstructured":"Cicenas J, Ra\u010dien\u0117 A. Anti-cancer drugs targeting protein kinases approved by FDA in 2020. Cancers (Basel). 2021;13(5):947. https:\/\/doi.org\/10.3390\/cancers13050947.","journal-title":"Cancers (Basel)"},{"key":"5218_CR29","first-page":"1","volume":"10","author":"J Cicenas","year":"2017","unstructured":"Cicenas J, Zalyte E, Rimkus A, Dapkus D, Noreika R, Urbonavicius S, JNK. p38, ERK, and SGK1 inhibitors in cancer. In Cancer signaling and therapeutics. MDPI. 2017;10:1.","journal-title":"MDPI"},{"key":"5218_CR30","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00432-016-2136-1","volume":"142","author":"J Cicenas","year":"2016","unstructured":"Cicenas J. The aurora kinase inhibitors in cancer research and therapy. J Cancer Res Oncol. 2016;142:1995\u20132012.","journal-title":"J Cancer Res Oncol"},{"issue":"4","key":"5218_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamaoncol.2020.7932","volume":"7","author":"HS Rugo","year":"2021","unstructured":"Rugo HS, Im S-A, Cardoso F, Cort\u00e9s J, Curigliano G, Musolino A, et al. Efficacy of Margetuximab vs Trastuzumab in patients with pretreated ERBB2-positive advanced breast cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2021;7(4):573\u201384.","journal-title":"JAMA Oncol"},{"issue":"5","key":"5218_CR32","first-page":"513","volume":"33","author":"S Faivre","year":"2006","unstructured":"Faivre S, Djelloul S, Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol. 2006;33(5):513\u201326.","journal-title":"Semin Oncol"},{"key":"5218_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/0975-8453.59519","volume":"1","author":"A Baldi","year":"2010","unstructured":"Baldi A. Computational approaches for drug design and discovery: an overview. Syst Rev Pharm. 2010;1:99\u2013105. https:\/\/doi.org\/10.4103\/0975-8453.59519.","journal-title":"Syst Rev Pharm"},{"issue":"7","key":"5218_CR34","first-page":"1181","volume":"32","author":"BS Bhadane","year":"2018","unstructured":"Bhadane BS, Patil MP, Maheshwari VL, Patil RH. Ethnopharmacology, phytochemistry, and biotechnological advances of family apocynaceae: a review. Phytochem Rev. 2018;32(7):1181\u2013210.","journal-title":"Phytochem Rev"},{"issue":"4","key":"5218_CR35","first-page":"248","volume":"22","author":"B Ali","year":"1995","unstructured":"Ali B, Bashir A, Banna N, Tanira MO. Central nervous system activity of Rhazya stricta (Decne) in mice. J Ethnopharmacol. 1995;22(4):248\u201353.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"5218_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0091-3057(97)00470-X","volume":"59","author":"B Ali","year":"1998","unstructured":"Ali B, Bashir A, Tanira MO. The effect of Rhazya stricta Decne, a traditional medicinal plant, on the forced swimming test in rats. Pharmacol Biochem Behav. 1998;59(2):547\u201350.","journal-title":"Pharmacol Biochem Behav"},{"key":"5218_CR37","first-page":"89","volume":"47","author":"SA Ghazanfar","year":"1993","unstructured":"Ghazanfar SA, Al-Al-Sabahi AM. Medicinal plants of Northern and central Oman (Arabia). J Ethnopharmacol. 1993;47:89\u201398.","journal-title":"J Ethnopharmacol"},{"issue":"194","key":"5218_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1095-8339.1891.tb01462.x","volume":"28","author":"JH Lace","year":"1891","unstructured":"Lace JH, Hemsley WB. A sketch of the vegetation of British Baluchistan, with descriptions of new species. J Bot Soc Lond. 1891;28(194):288\u2013327.","journal-title":"J Bot Soc Lond"},{"issue":"2","key":"5218_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/molecules26020488","volume":"26","author":"AE Mohammed","year":"2021","unstructured":"Mohammed AE, Abdul-Hameed ZH, Alotaibi MO, Bawakid NO, Sobahi TR, Abdel-Lateff A, Alarif WM. Chemical diversity and bioactivities of monoterpene Indole alkaloids (MIAs) from six apocynaceae genera. Molecules. 2021;26(2):488. https:\/\/doi.org\/10.3390\/molecules26020488.","journal-title":"Molecules"},{"key":"5218_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fitote.2018.04.018","volume":"128","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, Li W, Chen F-F, Zhang J-S, Tang Y-Q, Chen L, Yin SJF. Monoterpene indole alkaloids from Rhazya stricta. Fitoterapia. 2018;128:1\u20136.","journal-title":"Fitoterapia"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05218-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:08:13Z","timestamp":1773659293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-025-05218-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5218"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05218-w","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The fresh leaves of R. stricta were collected in June from the private land in Islamabad, Pakistan and then shade dried. Prior to collection, formal permission was obtained from the respective landowner. A professional taxonomist Prof. Dr. Zaheer-ud-din Khan from the Botany Department at Government University (GCU), Lahore, Pakistan, verified the authenticity of the collected plant. Additionally, a voucher specimen was submitted with the reference number 4013 to the herbarium at Government College University Lahore Pakistan. All the procedures were followed in accordance with relevant guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}